Global Coronavirus Diagnostics Market Size, Share and Forecast 2026 | TechSci Research

GLOBAL CORONAVIRUS DIAGNOSTICS MARKET

FORECAST & OPPORTUNITIES

2016 – 2026

MARKET INTELLIGENCE . CONSULTING

www.techsciresearch.com

2

Scope of ReportProduct of Interest (POI): Coronavirus Diagnostics

Review Period

2016 – 2019

Base Year

2020

Estimated Year

2021

Forecast Period

2022 – 2026

Year Range

Coronaviruses are a group of related RNA viruses that cause diseases in mammals andbirds. In humans and birds, they cause respiratory tract infections that can range frommild to lethal. Mild illnesses in humans include some cases of the common cold (which isalso caused by other viruses, predominantly rhinoviruses), while more lethal varieties cancause SARS, MERS, and COVID-19. In cows and pigs, they cause diarrhea, while in micethey cause hepatitis and encephalomyelitis.

Market Segmentation

REGION

• Europe

• North America

• South America

• Middle East & Africa

• Asia Pacific

FULL TEST TIME

• 1 Hours to 12 Hours

• Less Than 60 Minutes

• 13 Hours-24 Hours

• More Than 1 Days

END USER

• Hospitals

• Public Health Labs

• Private or Commercial Labs

• Physician Labs

• Others

USERS

• Multiple

• Single

TYPE OF TEST

• Molecular

• Serology

3

Table of Contents

S. No. Contents Page No.

1. Product Overview (Definition of product and major terminologies used in the report)

2. Research Methodology (Detailed description of the methodology used to conduct the research, Rawdata backup, list of all secondary sources, List of respondents for primary surveys)

3. Impact of COVID-19 on Global Coronavirus Diagnostics Market

4. Executive Summary (This chapter covers summary of the complete study.)

5.Voice of Customer (Brand Awareness, Challenges Faced Post Purchase, Factors Influencing Purchase Decision)

6.

Global Coronavirus Diagnostics Market Outlook, 2016-2026F (This chapter includes a brief overview of the product of interest market such as total market’s growth rate, expected growth rate, key growth levers, leading region, top grossing product Type of Tests, etc. It includes more of a qualitative information about the market.)

6.1. Market Size & Forecast

6.1.1. By Value (USD) & Volume (Units)

6.2. Market Share & Forecast

6.2.1. By Type of Test (Molecular v/s Serology)

6.2.2. By User (Multiple v/s Single)

6.2.3.By Full Test Time (1 Hours to 12 Hours, Less Than 60 Minutes, 13 Hours-24 Hours, More Than 1 Days)

6.2.4.By End User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Others)

6.2.5. By Company (2020)

6.2.6.By Region (Asia-Pacific, Europe, North America, South America and Middle East & Africa)

6.3. Product Market Map

4

Table of Contents


7. Asia-Pacific Coronavirus Diagnostics Market Outlook, 2016-2026F




7.2.1. By Type of Test

7.2.2. By User

7.2.3. By Full Test Time

7.2.4. By End User

7.2.5. By Country

7.3. Asia-Pacific: Country Analysis

7.3.1. China Coronavirus Diagnostics Market Outlook, 2016-2026F

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value (USD) & Volume (Units)

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Type of Test

7.3.1.2.2. By User

7.3.1.2.3. By Full Test Time

7.3.1.2.4. By End User

7.3.2. India Coronavirus Diagnostics Market Outlook, 2016-2026F


5

Table of Contents





7.3.2.2.2. By User



7.3.3. Japan Coronavirus Diagnostics Market Outlook, 2016-2026F





7.3.3.2.2. By User



7.3.4. South Korea Coronavirus Diagnostics Market Outlook, 2016-2026F





7.3.4.2.2. By User



6

Table of Contents


7.3.5. Australia Coronavirus Diagnostics Market Outlook, 2016-2026F





7.3.5.2.2. By User



7.3.6. Singapore Coronavirus Diagnostics Market Outlook, 2016-2026F





7.3.6.2.2. By User



7.3.7. Thailand Coronavirus Diagnostics Market Outlook, 2016-2026F





7.3.7.2.2. By User



7

Table of Contents


8. Europe Coronavirus Diagnostics Market Outlook, 2016-2026F





8.2.2. By User


8.2.4. By End User

8.2.5. By Country

8.3. Europe: Country Analysis

8.3.1. France Coronavirus Diagnostics Market Outlook, 2016-2026F





8.3.1.2.2. By User



8.3.2. Germany Coronavirus Diagnostics Market Outlook, 2016-2026F




8

Table of Contents



8.3.2.2.2. By User



8.3.3. United Kingdom Coronavirus Diagnostics Market Outlook, 2016-2026F





8.3.3.2.2. By User



8.3.4. Italy Coronavirus Diagnostics Market Outlook, 2016-2026F





8.3.4.2.2. By User



9

Table of Contents


8.3.5. Spain Coronavirus Diagnostics Market Outlook, 2016-2026F





8.3.5.2.2. By User



8.3.6. Russia Coronavirus Diagnostics Market Outlook, 2016-2026F





8.3.6.2.2. By User



10

Table of Contents


9. North America Coronavirus Diagnostics Market Outlook, 2016-2026F





9.2.2. By User


9.2.4. By End User

9.2.5. By Country (United States, Canada, Mexico)

9.3. North America: Country Analysis

9.3.1. United States Coronavirus Diagnostics Market Outlook, 2016-2026F





9.3.1.2.2. By User



11

Table of Contents


9.3.2. Canada Coronavirus Diagnostics Market Outlook, 2016-2026F





9.3.2.2.2. By User



9.3.3. Mexico Coronavirus Diagnostics Market Outlook, 2016-2026F





9.3.3.2.2. By User



12

Table of Contents


10. South America Coronavirus Diagnostics Market Outlook, 2016-2026F





10.2.2. By User


10.2.4. By End User

10.2.5. By Country (Brazil, Argentina, Colombia)

10.3. South America: Country Analysis

10.3.1. Brazil Coronavirus Diagnostics Market Outlook, 2016-2026F


10.3.1.1.1 By Value (USD) & Volume (Units)



10.3.1.2.2. By User


10.3.1.2.4. By End User

13

Table of Contents


10.3.2. Argentina Coronavirus Diagnostics Market Outlook, 2016-2026F





10.3.2.2.2. By User


10.3.2.2.4. By End User

10.3.3. Colombia Coronavirus Diagnostics Market Outlook, 2016-2026F





10.3.2.2.2. By User


10.3.2.2.4. By End User

14

Table of Contents


11. Middle East & Africa Coronavirus Diagnostics Market Outlook, 2016-2026F





11.2.2. By User


11.2.4. By End User

11.2.5. By Country (South Africa, Saudi Arabia, UAE, Kuwait)

11.3. Middle East & Africa : Country Analysis

11.3.1. South Africa Coronavirus Diagnostics Market Outlook, 2016-2026F





11.3.1.2.2. By User


11.3.1.2.4. By End User

15

Table of Contents


11.3.2. Saudi Arabia Coronavirus Diagnostics Market Outlook, 2016-2026F





11.3.2.2.2. By User


11.3.2.2.4. By End User

11.3.3. UAE Coronavirus Diagnostics Market Outlook, 2016-2026F





11.3.3.2.2. By User


11.3.3.2.4. By End User

16

Table of Contents


11.3.4. Kuwait Coronavirus Diagnostics Market Outlook, 2016-2026F





11.3.4.2.2. By User


11.3.4.2.4. By End User

11.3.5. Iran Coronavirus Diagnostics Market Outlook, 2016-2026F





11.3.5.2.2. By User


11.3.5.2.4. By End User

17

Table of Contents


12. Market Dynamics (This chapter assesses the major demand drivers and restraints.)

12.1. Drivers

12.2. Challenges

13.Market Trends & Developments (This section captures recent trends pertaining to manufacturing or consumption, market movements in terms of points of production and consumption, advancements and development)

14. Competitive Landscape

14.1. Competition Outlook

14.2. Global Players Profiled (Leading Companies)

14.2.1. Company Details

14.2.2. Products & Services

14.2.3. Financials (As Reported)

14.2.4. Key Market Focus & Geographical Presence

14.2.5. Recent Developments

14.2.6. Key Management Personnel

15.Strategic Recommendations (Based on the findings of the report strategic recommendations on how to enter and expand market share)

16. About Us & Disclaimer

19

Research Methodology

✓ Identifying Key Opinion

Leaders

✓ Questionnaire Design

✓ In-depth Interviews

Data Collection

Developing List of Respondents

Formulating Questionnaire

Market Profiling

Data Validation

Data Analysis

In-depth secondary research was conducted to

determine top players in the global coronavirus

diagnostics market, overall market size and segmental

market size.

In order to conduct industry experts’

interviews, TechSci formulated a detailed

discussion guide.

List of industry players and industry

specialists was developed.

TechSci conducted interviews with

industry experts and industry players for data collection and

verification.

Data obtained as a result of primary and secondary research was

validated through rigorous

triangulation.

The data was scrutinized using MS-Excel, statistical

tools and internal proprietary database to obtain qualitative and

quantitative insights about the global coronavirus

diagnostics market.

Data Collection

Data Filter& Analysis

Research &Intelligence

ActionableInsights

BusinessSolution

Primary Research Desk Research Company Analysis

✓ Recent Developments

✓ Market Changing

Aspects/Dynamics

✓ Government Policies

✓ Conclusion

✓ Market Participants

✓ Key Strengths

✓ LinkedIn✓ TechSci Internal

Database

✓ Factiva✓ Hoovers

Paid Sources

✓ Company Websites✓ Company Annual

Reports✓ White Paper Study✓ Financial Reports✓ Investor

Presentations✓ Regulatory Body✓ Associations, etc.

Secondary Research

Primary Research

20


Baseline Methodology

Our dedicated team of industry experts has monitored and analyzed various aspects of the global coronavirus diagnostics market. The

team has analyzed the outlook of various segments of this market, while considering the major influencing factors such as increase

coronavirus diagnostics. The study includes market forecasting, which would enable our clients to take better decisions while planning

their strategy to achieve sustainability in the global coronavirus diagnostics market.

Methodology Followed for Calculation of Market Size:

• Market Size by Value & Volume : Market size, in terms of value, for the year 2020 was calculated based on information collected

through exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as coronavirus

diagnostics manufacturers, channel partners, market influencers & end users, industry experts, and other industry participants.

• The team interviewed more than 15 – 20 coronavirus diagnostics manufacturers, 100 – 120 end users, and 15 – 20 industry experts

and other value chain stakeholders in the global coronavirus diagnostics market to obtain the overall market size from 2016 to 2020,

which was validated by the Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to

arrive at the market size data during 2016-2020.

21


• Respondents were asked about the current and future market growth rates, market shares by type of test, by user, by full test time,

by end user, by company and by each region. Removing the outlier responses, the geometric mean of growth estimates and

provider wise revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue

shares generated across various type were further triangulated from other stakeholders.

Methodology Followed for Calculation of Market Shares:

• Market shares by type of test, by user, by full test time, by end user, by company and by each region were calculated based on the

responses received through primary surveys with industry experts, in which the respondents were asked about the market shares

or revenue generated from various types of coronavirus diagnostics. The final shares were calculated by taking the geometric mean

of the responses gathered from key opinion leaders after eliminating the outliers.

Methodology Followed for Forecasting:

• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey

results in SPSS/Tableau Software.

• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast

global coronavirus diagnostics market, TechSci Research used various forecast techniques such as:

✓ Moving Average

✓ Time Series Analysis

✓ Regression Analysis

✓ Econometric and Judgmental Analysis

22


TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research

also used the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It

should be noted that the figures compiled are only for the organized market including market share data. The currency used in the report is the

United States Dollar (USD), with the market size indicated in USD million.

Partial List of Companies Interviewed Key Secondary Sources

▪ Abbott Laboratories

▪ Altona Diagnostics GmbH

▪ BioMerieux SA

▪ Bio-Rad Laboratories, Inc.

▪ Danaher Corporation

▪ F.Hoffmann-La Roche Ltd

▪ GSK Biologicals SA

▪ Mylab Discovery Solutions Pvt. Ltd.

▪ Seegene Inc.

▪ Siemens AG

▪ Thermo Fisher Scientific Inc.

▪ PerkinElmer, Inc.

▪ Quest Diagnostics Inc.

▪ Hologic, Inc.

▪ Quidel Corporation

▪ World Bank

▪ International Monetary Fund (IMF)

▪ TechSci Research Proprietary Database &

Knowledge Repository

▪ Company Annual Reports

▪ Industry Magazines

▪ Industry Reports

▪ News Dailies

▪ Credible Paid Databases

23

Industry Brief

According to TechSci Research report, “Global Coronavirus Diagnostics Market By Type of Test (Molecular v/s Serology), By User (Multiple v/s Single),

By Full Test Time (1 Hour - 12 Hours, Less Than 60 Minutes, 13 Hours - 24 Hours, More Than 1 Day), By End User (Hospitals, Public Health Labs,

Private or Commercial Labs, Physician Labs, Others), By Region, Competition, Forecast & Opportunities, 2026”, the global coronavirus diagnostics

market is expected to reach USD15579.56 million by 2026 on account of increasing R&D activities related to coronavirus diagnostics and treatment by

major companies and research laboratories around the globe. Additionally, increasing funding & grants by various governments around the world to find

out efficient diagnostic and treatment methods is further expected to spur the market over the next few years. Furthermore, increasing healthcare

spending and rising need to protect the population from such outbreaks are expected to positively impact the growth of market in the coming years.

However, high cost of diagnostics can hamper the growth of market, especially in the developing economies in the near term. Additionally, limited

availability of diagnostic kits can hinder the growth of market.

The global coronavirus diagnostics market is segmented based on type of test, user, full test time, end user, company and region. Based on type of

test, the market can be bifurcated into molecular and serological tests. The serology tests segment is expected to witness significant growth during the

forecast period. Based on full test time, the market can be fragmented into less than 60 minutes, 1 hour to 12 hours, 13 hours - 24hours and more than

1 day. 1 hour to 12 hours segment is currently dominating the market is expected to do so in the forecast period as well as the methods that are

available right now take this much duration in the diagnosis of COVID-19 since they involve real time PCR test followed by gene fingerprinting which

usually takes time. The less than 60 minutes segment is also expected to witness significant growth during the forecast period because California-

based molecular diagnostics company Cepheid Inc., a subsidiary of Danaher Corporation, has developed a rapid coronavirus diagnostic test with

detection time of about 45 minutes and has got the approval from the United States Food and Drug Administration (FDA) also. Based on end user, the

market can be segmented into hospitals, public health labs, private or commercial labs, physician labs and others. The hospitals segment is currently

the dominating segment and is expected to continue to do in future as well owing to the presence of sophisticated diagnostic and treatment facilities in

the hospitals.

F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc., Mylab Discovery Solutions Pvt. Ltd.,

Bio-Rad Laboratories, Inc., BioMerieux SA, GSK Biologicals SA, Altona Diagnostics GmbH, Seegene Inc., PerkinElmer, Inc., Quest Diagnostics Inc.,

Hologic, Inc., Quidel Corporation are some of the leading players operating in the global coronavirus diagnostics market. The companies operating in

the market are increasingly focusing on developing low cost diagnostic kits that offer high efficiency and accuracy. For instance, recently Pune (India)

based molecular diagnostic company Mylab Discovery Solutions Pvt. Ltd. has become the first Indian company to have received the validation for its

COVID-19 diagnostic test kits also known as the Reverse Transcription Polymerase Chain Reaction (RT-PCR) tests by the Drug Controller of India,

after the National Institute of Virology validated its test.

“Europe and Asia Pacific are expected to dominate the coronavirus diagnostics market during the forecast period. Increasing investments in R&D

activities along with strong support from the governments in both the regions are further expected to create huge market opportunities for diagnostic

players over the next few years.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting

firm.

24

Sample Data - Snapshot

25%25%25%25%25%25%25%25%25%25%25%

25%25%25%25%25%25%25%25%25%25%25%

25%25%25%25%25%25%25%25%25%25%25%

25%25%25%25%25%25%25%25%25%25%25%

2016

2017

2018

2019

2020

2021E

2022F

2023F

2024F

2025F

2026F

1 Hours to 12 Hours Less Than 60 Minutes 13 Hours-24 Hours More Than 1 Days

Asia-Pacific Coronavirus Diagnostics Market Share, By Full Test Time, By Value, 2016–2026F

5.0

0

6.0

0

7.0

0

8.0

0

9.0

0

10

.00

11

.00

12

.00

13

.00

14

.00

15

.00

10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00 90.00 100.00 110.00

2016 2020 2021E 2026F

By Value (USD Million) By Volume (Units)

Global Coronavirus Diagnostics Market Size, By Value (USD Million) & By Volume (Units), 2016–2026F

20%20%20%20%20%20%20%20%20%20%20%

20%20%20%20%20%20%20%20%20%20%20%

20%20%20%20%20%20%20%20%20%20%20%

20%20%20%20%20%20%20%20%20%20%20%

20%20%20%20%20%20%20%20%20%20%20%

2016

2017

2018

2019

2020

2021E

2022F

2023F

2024F

2025F

2026F

Hospitals Public Health Labs Private or Commercial Labs Physician Labs Others

India Coronavirus Diagnostics Market Share, By End User, By Value, 2016–2026F

25

Report Ordering

Report Name: GLOBAL CORONAVIRUS DIAGNOSTICS MARKET

FORECAST & OPPORTUNITIES2016 – 2026

To View Sample OR Purchase Report

License Type Price

Single User License $4900

Multi-User License $5900

Custom Research License $8900

https://www.techsciresearch.com/report/coronavirus-diagnostics-market/4574.html

About Us & Disclaimer

TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in

number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The

proprietary forecasting models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’

model of a country, regional and global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich

evaluation of the opportunities available in the market.

Related Reports

• Global Coronavirus Vaccine Market By Infection Type (HCoV-229E, HCoV-OC43, SARS-CoV, New Haven CoV, HKU1-CoV, MERS-CoV, SARS-CoV-2,

Others), By Vaccine Type (Inactivated Coronavirus Vaccine, Live Attenuated Coronavirus Vaccine, S-Protein Based Coronavirus Vaccine), By

Product Type (Monovalent Vaccine v/s Multivariant Vaccine), By Route of Administration (Oral, Intramuscular, Subcutaneous), By Patient

Type (Pediatric v/s Adult), By End User (Hospitals, Clinics, Research Institutes, Others), By Region, Forecast & Opportunities, 2026

• Global 3D Mobile C-Arm Market By Application (Orthopedics, Trauma, Cardiovascular, Urology, Gastroenterology, Neurology, Others) By End

Users (Hospitals, Specialty Clinics, Ambulatory Surgical Clinics) By Region, Competition Forecast & Opportunities, 2026.

The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely,accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considersreliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors oromissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of thisreport. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative marketsize and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.

TechSci Research – North America708 Third Avenue, Manhattan,

New York, United StatesTel: +1- 646- 360- 1656

Email: [email protected] www.techsciresearch.com

Disclaimer

TechSci Research – Europe54, Old brook, Bretton,

Peterborough, United Kingdom


TechSci Research – Asia-PacificB – 44, Sector – 57, Noida, National Capital

Region, U.P. - IndiaTel: +91-120-4523900


Health & Medicine

Global Coronavirus Diagnostics Market Size, Share and Forecast 2026 | TechSci Research